Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors

Ann N Y Acad Sci. 2005 May:1041:17-21. doi: 10.1196/annals.1282.004.

Abstract

This study defines the pharmacologic characteristics of LGR7 and LGR8, the receptors for H2 relaxin and INSL3 respectively, and determines the relative activity of relaxin-related peptides. We show, for the first time, the availability of two binding sites at LGR8 and confirm the presence of two sites at LGR7. Relaxin-related peptides had differing rank orders of affinity and potency at LGR7 and LGR8, but chimeric receptors were highly similar to their ectodomain-origin native receptors. The high-affinity site on the ectodomain coupled efficiently to cAMP production, whereas the low-affinity site in the transmembrane region coupled with decreased efficiency.

MeSH terms

  • Animals
  • Binding Sites
  • Cyclic AMP / biosynthesis
  • Cyclic AMP / metabolism
  • Insulin / metabolism
  • Ligands
  • Models, Biological
  • Proteins / metabolism
  • Rats
  • Receptors, G-Protein-Coupled / metabolism*
  • Receptors, Peptide / metabolism*
  • Relaxin / analogs & derivatives*
  • Relaxin / metabolism*

Substances

  • Insulin
  • Leydig insulin-like protein
  • Ligands
  • Proteins
  • Receptors, G-Protein-Coupled
  • Receptors, Peptide
  • Rxfp1 protein, rat
  • relaxin receptors
  • Relaxin
  • Cyclic AMP